Formulation design of lyotropic liquid crystalline nanoparticles governs mesophase organization, colloidal stability, and in vitro NAD(+) release.
- DOI
- 10.1016/j.ijpharm.2026.127425
- Published
- 2026 Sep 16
- Container
- International journal of pharmaceutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijpharm.2026.127425,
title = {Formulation design of lyotropic liquid crystalline nanoparticles governs mesophase organization, colloidal stability, and in vitro NAD(+) release.},
author = {Tsichlis I and Kalyva K and Athanasaki A and Chrissopoulou K and Anastasiadis SH and Demetzos C},
year = {2026},
journal = {International journal of pharmaceutics},
doi = {10.1016/j.ijpharm.2026.127425},
url = {https://doi.org/10.1016/j.ijpharm.2026.127425}
}RIS
TY - JOUR TI - Formulation design of lyotropic liquid crystalline nanoparticles governs mesophase organization, colloidal stability, and in vitro NAD(+) release. AU - Tsichlis I AU - Kalyva K AU - Athanasaki A AU - Chrissopoulou K AU - Anastasiadis SH AU - Demetzos C PY - 2026 JO - International journal of pharmaceutics DO - 10.1016/j.ijpharm.2026.127425 UR - https://doi.org/10.1016/j.ijpharm.2026.127425 ER -
APA
I, T., K, K., A, A., K, C., SH, A., & C, D. (2026). Formulation design of lyotropic liquid crystalline nanoparticles governs mesophase organization, colloidal stability, and in vitro NAD(+) release.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127425
Source records
- pubmed · retrieved 2026-09-26T09:58:46.720Z